METHOD FOR DIAGNOSTICS OF NON-DIFFERENTIAL CONNECTIVE TISSUE DYSPLASIA IN PREGNANT WOMEN Russian patent published in 2017 - IPC G01N33/68 

FIELD: medicine.

SUBSTANCE: in pregnant women on week 22-36 of gestation the level of the N-terminal propeptide of type III procollagen (PIIINP) is determined in peripheral venous blood and at a value of more than 52 pg/ml, but less than 101 pg/ml, non-differentiated connective tissue dysplasia is diagnosed. Method application makes it possible to diagnose non-differentiated connective tissue dysplasia in pregnant women on week 22-36 of pregnancy with high accuracy, sensitivity and specificity, which makes it possible to classify these patients as a high-risk group of complications of pregnancy and childbirth and to timely prevent them.

EFFECT: expanded arsenal of diagnostic tools and simplified determination of non-differentiated connective tissue dysplasia in pregnant women on week 22-36 of gestation.

1 tbl, 5 ex